DehydraTECH-CBD

DehydraTECH-CBD is a proprietary oral formulation of cannabidiol (CBD) developed by Lexaria Bioscience Corp using its patented DehydraTECH drug delivery platform. The technology involves combining the active ingredient with fatty acids, such as oleic acid, and applying it to a substrate to enhance intestinal absorption and bypass first-pass liver metabolism via the lymphatic system. This process significantly improves the bioavailability and speed of onset of CBD compared to standard oil-based formulations. Lexaria is primarily investigating DehydraTECH-CBD for the treatment of hypertension, where clinical studies have demonstrated its ability to reduce blood pressure and arterial stiffness. The formulation is also being explored for other indications including diabetes and seizure disorders.

Brand names

DehydraTECH-CBD

Other names

Lexaria CBDDehydraTECH-processed CBD